2020 Thrombosis Canada Needs Assessment

Question Title

* 1. Please enter your profession

Question Title

* 2. Have you attended previous Thrombosis Canada conferences?

Yes

Question Title

* 3. Most of the patients with thrombosis that I see have problems in the following areas, so I would be interested in CPD on these topics:

Question Title

* 4. List the two diagnoses/clinical problems in thrombosis that you most frequently encounter:

Question Title

* 5. What skills or procedures related to thrombosis would you benefit from learning or reviewing?

Question Title

* 6. Which of the following subject areas in thrombosis would you benefit in learning more about? (Please check off all that apply):

	Very interested	Interested	Somewhat interested	Low interest	Not interested	N/A
Thrombosis management in the emergency department	Thrombosis management in the emergency department Very interested	Thrombosis management in the emergency department Interested	Thrombosis management in the emergency department Somewhat interested	Thrombosis management in the emergency department Low interest	Thrombosis management in the emergency department Not interested	Thrombosis management in the emergency department N/A
Management of clots at unusual sites	Management of clots at unusual sites Very interested	Management of clots at unusual sites Interested	Management of clots at unusual sites Somewhat interested	Management of clots at unusual sites Low interest	Management of clots at unusual sites Not interested	Management of clots at unusual sites N/A
VTE and women's health	VTE and women's health Very interested	VTE and women's health Interested	VTE and women's health Somewhat interested	VTE and women's health Low interest	VTE and women's health Not interested	VTE and women's health N/A
Anticoagulation and renal failure	Anticoagulation and renal failure Very interested	Anticoagulation and renal failure Interested	Anticoagulation and renal failure Somewhat interested	Anticoagulation and renal failure Low interest	Anticoagulation and renal failure Not interested	Anticoagulation and renal failure N/A
Anticoagulants and antiplatelet therapy	Anticoagulants and antiplatelet therapy Very interested	Anticoagulants and antiplatelet therapy Interested	Anticoagulants and antiplatelet therapy Somewhat interested	Anticoagulants and antiplatelet therapy Low interest	Anticoagulants and antiplatelet therapy Not interested	Anticoagulants and antiplatelet therapy N/A
Diagnosis of DVT/PE	Diagnosis of DVT/PE Very interested	Diagnosis of DVT/PE Interested	Diagnosis of DVT/PE Somewhat interested	Diagnosis of DVT/PE Low interest	Diagnosis of DVT/PE Not interested	Diagnosis of DVT/PE N/A
Thrombosis in indigenous people	Thrombosis in indigenous people Very interested	Thrombosis in indigenous people Interested	Thrombosis in indigenous people Somewhat interested	Thrombosis in indigenous people Low interest	Thrombosis in indigenous people Not interested	Thrombosis in indigenous people N/A
Primary prevention of cancer associated thrombosis	Primary prevention of cancer associated thrombosis Very interested	Primary prevention of cancer associated thrombosis Interested	Primary prevention of cancer associated thrombosis Somewhat interested	Primary prevention of cancer associated thrombosis Low interest	Primary prevention of cancer associated thrombosis Not interested	Primary prevention of cancer associated thrombosis N/A
Periprocedural management of anticoagulation	Periprocedural management of anticoagulation Very interested	Periprocedural management of anticoagulation Interested	Periprocedural management of anticoagulation Somewhat interested	Periprocedural management of anticoagulation Low interest	Periprocedural management of anticoagulation Not interested	Periprocedural management of anticoagulation N/A
Warfarin use in 2020: who, what, why, when, how	Warfarin use in 2020: who, what, why, when, how Very interested	Warfarin use in 2020: who, what, why, when, how Interested	Warfarin use in 2020: who, what, why, when, how Somewhat interested	Warfarin use in 2020: who, what, why, when, how Low interest	Warfarin use in 2020: who, what, why, when, how Not interested	Warfarin use in 2020: who, what, why, when, how N/A
Acute and long-term management of VTE	Acute and long-term management of VTE Very interested	Acute and long-term management of VTE Interested	Acute and long-term management of VTE Somewhat interested	Acute and long-term management of VTE Low interest	Acute and long-term management of VTE Not interested	Acute and long-term management of VTE N/A
Thrombophilia testing: pearls and pitfalls	Thrombophilia testing: pearls and pitfalls Very interested	Thrombophilia testing: pearls and pitfalls Interested	Thrombophilia testing: pearls and pitfalls Somewhat interested	Thrombophilia testing: pearls and pitfalls Low interest	Thrombophilia testing: pearls and pitfalls Not interested	Thrombophilia testing: pearls and pitfalls N/A
Peripheral vascular disease	Peripheral vascular disease Very interested	Peripheral vascular disease Interested	Peripheral vascular disease Somewhat interested	Peripheral vascular disease Low interest	Peripheral vascular disease Not interested	Peripheral vascular disease N/A
Distal/below knee DVT	Distal/below knee DVT Very interested	Distal/below knee DVT Interested	Distal/below knee DVT Somewhat interested	Distal/below knee DVT Low interest	Distal/below knee DVT Not interested	Distal/below knee DVT N/A
Superficial venous thrombosis	Superficial venous thrombosis Very interested	Superficial venous thrombosis Interested	Superficial venous thrombosis Somewhat interested	Superficial venous thrombosis Low interest	Superficial venous thrombosis Not interested	Superficial venous thrombosis N/A
Immobility and thrombosis risk	Immobility and thrombosis risk Very interested	Immobility and thrombosis risk Interested	Immobility and thrombosis risk Somewhat interested	Immobility and thrombosis risk Low interest	Immobility and thrombosis risk Not interested	Immobility and thrombosis risk N/A
Thrombosis management in special populations (obesity, thrombophilia, elderly, etc)	Thrombosis management in special populations (obesity, thrombophilia, elderly, etc) Very interested	Thrombosis management in special populations (obesity, thrombophilia, elderly, etc) Interested	Thrombosis management in special populations (obesity, thrombophilia, elderly, etc) Somewhat interested	Thrombosis management in special populations (obesity, thrombophilia, elderly, etc) Low interest	Thrombosis management in special populations (obesity, thrombophilia, elderly, etc) Not interested	Thrombosis management in special populations (obesity, thrombophilia, elderly, etc) N/A
Venous thromboembolism prophylaxis following hip and knee replacement surgery	Venous thromboembolism prophylaxis following hip and knee replacement surgery Very interested	Venous thromboembolism prophylaxis following hip and knee replacement surgery Interested	Venous thromboembolism prophylaxis following hip and knee replacement surgery Somewhat interested	Venous thromboembolism prophylaxis following hip and knee replacement surgery Low interest	Venous thromboembolism prophylaxis following hip and knee replacement surgery Not interested	Venous thromboembolism prophylaxis following hip and knee replacement surgery N/A
Estimating bleeding risk while on anticoagulants	Estimating bleeding risk while on anticoagulants Very interested	Estimating bleeding risk while on anticoagulants Interested	Estimating bleeding risk while on anticoagulants Somewhat interested	Estimating bleeding risk while on anticoagulants Low interest	Estimating bleeding risk while on anticoagulants Not interested	Estimating bleeding risk while on anticoagulants N/A
Treatment of cancer associated thrombosis	Treatment of cancer associated thrombosis Very interested	Treatment of cancer associated thrombosis Interested	Treatment of cancer associated thrombosis Somewhat interested	Treatment of cancer associated thrombosis Low interest	Treatment of cancer associated thrombosis Not interested	Treatment of cancer associated thrombosis N/A
AFib and other cardiac disease	AFib and other cardiac disease Very interested	AFib and other cardiac disease Interested	AFib and other cardiac disease Somewhat interested	AFib and other cardiac disease Low interest	AFib and other cardiac disease Not interested	AFib and other cardiac disease N/A

Other (please specify)

Question Title

* 7. Where do you go to get information about thrombosis (website(s), publication, colleague, etc.)? Please list all sources.

Question Title

* 8. Additional comments

Question Title

* 9. Name (Optional for $10 discount to conference)

Question Title

* 10. E-mail address (Optional for $10 discount to conference)